← Back to Clinical Trials
Recruiting NCT06502613
Idiopathic Scoliosis New Onset and Melatonin Phase Delay in Children
Trial Parameters
Condition Scoliosis Idiopathic
Sponsor Second Affiliated Hospital of Wenzhou Medical University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 956
Sex ALL
Min Age 6 Years
Max Age 15 Years
Start Date 2024-08-01
Completion 2027-07-01
All Conditions
Brief Summary
This study aimed to investigate the prevalence and clinical significance of melatonin phase delay in children with new onset and progressive idiopathic scoliosis (IS).
Eligibility Criteria
Inclusion Criteria: * Collect saliva according to standards and complete melatonin testing * Complete scoliometer or X-ray assess scoliosis * Skeletally immature (Risser Sign 0-3) * Age between 6 and 15 * Patients can understand and complete the MEQ-5, PSQ, and PSQI Questionnaire at baseline and follow-up visits * Informed Consent Form signed by subject or the guardian Exclusion Criteria: \-
Related Trials
NCT06502613
Idiopathic Scoliosis New Onset and Melatonin Phase Delay in Children
View Trial →
NCT05830825
PMCF (Post-Market Clinical Follow-up) Study on The Tether™ in UK (United Kingdom)
View Trial →
NCT06563141
A Suggested Rehabilitation Protocol for the Treatment of C-shape Scoliosis
View Trial →